UNIGE document Scientific Article
previous document  unige:96882  next document
add to browser collection
Title

Successful treatment of neonatal atypical hemolytic uremic syndrome with C5 monoclonal antibody

Authors
Gonzalez, E
Published in Archives de pédiatrie. 2016, vol. 23, no. 3, p. 283-6
Abstract Hemolytic uremic syndrome (HUS) is rare in neonates. We report the case of atypical HUS (aHUS) revealed by neonatal seizures. This 18-day-old baby presented with repeated clonus of the left arm and eye deviation. Four days earlier, she had suffered from gastroenteritis (non-bloody diarrhea and vomiting without fever). Her work-up revealed hemolytic anemia (120 g/L), thrombocytopenia (78 g/L), and impaired renal function (serum creatinine=102 μmol/L) compatible with the diagnosis of HUS. Levels of C3 and C4 in the serum were normal. Shiga-toxin in the stools as well as the IgM and IgG against Escherichia coli O157 were negative. ADAMTS 13 deficiency, inborn error of the cobalamin pathway, deficiency in the H and I protein, and factor H antibodies were excluded and we concluded in aHUS. Genetic screening of the alternative complement pathway was normal. Cerebral magnetic resonance imaging performed after 24 h and 1 week showed restricted diffusion areas with periventricular white matter ischemic-hemorrhagic lesions. Extensive infectious work-up was negative. Upon admission the baby received antiepileptic drugs and 2 days later C5 monoclonal antibody (eculizumab) and two transfusions of packed erythrocytes because the hemoglobin value had dropped to 55 g/L. The platelet value was minimal at 30 g/L. Renal function normalized in 48 h without dialysis and neurological examination was normal in 1 week. She was discharged from the hospital at day 10 with eculizumab perfusions (300 mg) planned every 3 weeks. After 24 months, she was relapse-free and seizure-free, with a normal neurological examination.
Keywords Antibodies, Monoclonal, Humanized/therapeutic useAtypical Hemolytic Uremic Syndrome/drug therapyFemaleHumansInfant, NewbornRemission Induction
Identifiers
PMID: 26775886
Full text
Article (Published version) (372 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Citation
(ISO format)
ANASTAZE, Karine et al. Successful treatment of neonatal atypical hemolytic uremic syndrome with C5 monoclonal antibody. In: Archives de pédiatrie, 2016, vol. 23, n° 3, p. 283-6. https://archive-ouverte.unige.ch/unige:96882

66 hits

0 download

Update

Deposited on : 2017-09-19

Export document
Format :
Citation style :